Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ISIS 14803: Began Phase I/II testing

Isis Pharmaceuticals Inc. (ISIP), Carlsbad, Calif.
Product: ISIS 14803

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE